Literature DB >> 21396369

A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.

Banny S Wong1, Michael Camilleri, Paula J Carlson, Maria E Guicciardi, Duane Burton, Sanna McKinzie, Archana S Rao, Alan R Zinsmeister, Gregory J Gores.   

Abstract

BACKGROUND & AIMS: Bile acid (BA) malabsorption of moderate severity is reported in 32% of patients with chronic unexplained diarrhea, including diarrhea-predominant irritable bowel syndrome (IBS-D). We hypothesized that variants of genes regulating hepatic BA synthesis play a role in IBS-D.
METHODS: In 435 IBS and 279 healthy subjects, we tested individual associations of 15 common single nucleotide polymorphisms (SNPs) from 7 genes critical to BA homeostasis with symptom-based subgroups using dominant genetic models. In a subset of 238 participants, we tested association with colonic transit. SNP-SNP interactions were investigated based on known protein interactions in BA homeostasis. The function of SNP rs17618244 in Klothoβ (KLB) was evaluated using a protein stability assay in HEK293 cells.
RESULTS: SNP rs17618244 (Arg728Gln in KLB) is associated with colonic transit at 24 hours. G allele (Arg728) compared with A allele (Gln728) is associated with accelerated colonic transit (P=.0007) in the overall cohort; this association was restricted to IBS-D (P=.0018). Interaction tests of KLB rs17618244 with 3 nonsynonymous SNPs of fibroblast growth factor receptor 4 (FGFR4) revealed that rs1966265 (Val10Ile) and rs351855 (Gly388Arg) modulate rs1768244's association with colonic transit in IBS-D (P=.0025 and P=.0023, respectively). KLB Arg728 significantly reduced protein stability compared with KLB Gln728, demonstrating KLB rs17618244's functional significance. No significant associations with symptom-based subgroups of IBS were detected.
CONCLUSIONS: A functional KLB gene variant mediating protein stability associates with colonic transit in IBS-D. This association is modulated by 2 genetic variants in FGFR4. The FGF19-FGFR4-KLB pathway links regulation of BA synthesis to colonic transit in IBS-D.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396369      PMCID: PMC3109206          DOI: 10.1053/j.gastro.2011.02.063

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  40 in total

1.  The proximal colonic motor response to rectal mechanical and chemical stimulation.

Authors:  P A Bampton; P G Dinning; M L Kennedy; D Z Lubowski; I J Cook
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-03       Impact factor: 4.052

2.  Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer.

Authors:  Sholom Wacholder; Nathaniel Rothman; Neil Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-06       Impact factor: 4.254

3.  Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein.

Authors:  S Ito; S Kinoshita; N Shiraishi; S Nakagawa; S Sekine; T Fujimori; Y I Nabeshima
Journal:  Mech Dev       Date:  2000-11       Impact factor: 1.882

4.  Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.

Authors:  Archana S Rao; Banny S Wong; Michael Camilleri; Suwebatu T Odunsi-Shiyanbade; Sanna McKinzie; Michael Ryks; Duane Burton; Paula Carlson; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2010-08-04       Impact factor: 22.682

5.  Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man.

Authors:  H S Mekjian; S F Phillips; A F Hofmann
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

6.  Performance characteristics of scintigraphic transit measurements for studies of experimental therapies.

Authors:  F Cremonini; B P Mullan; M Camilleri; D D Burton; M R Rank
Journal:  Aliment Pharmacol Ther       Date:  2002-10       Impact factor: 8.171

7.  Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders.

Authors:  H J Kim; M Camilleri; P J Carlson; F Cremonini; I Ferber; D Stephens; S McKinzie; A R Zinsmeister; R Urrutia
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

8.  Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test.

Authors:  S Wildt; S Nørby Rasmussen; J Lysgård Madsen; J J Rumessen
Journal:  Scand J Gastroenterol       Date:  2003-08       Impact factor: 2.423

9.  Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.

Authors:  Thomas A Kerr; Shigeru Saeki; Manfred Schneider; Karen Schaefer; Sara Berdy; Thadd Redder; Bei Shan; David W Russell; Margrit Schwarz
Journal:  Dev Cell       Date:  2002-06       Impact factor: 12.270

10.  Redundant pathways for negative feedback regulation of bile acid production.

Authors:  Li Wang; Yoon-Kwang Lee; Donnie Bundman; Yunqing Han; Sundararajah Thevananther; Chang Soo Kim; Steven S Chua; Ping Wei; Richard A Heyman; Michael Karin; David D Moore
Journal:  Dev Cell       Date:  2002-06       Impact factor: 12.270

View more
  37 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

Review 3.  The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

Authors:  Michael Camilleri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-07       Impact factor: 46.802

4.  Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.

Authors:  Banny S Wong; Michael Camilleri; Paula Carlson; Sanna McKinzie; Irene Busciglio; Olga Bondar; Roy B Dyer; Jesse Lamsam; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2012-05-18       Impact factor: 11.382

5.  Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.

Authors:  Banny S Wong; Michael Camilleri; Paula J Carlson; Suwebatu Odunsi-Shiyanbade; Sanna McKinzie; Irene Busciglio; Duane Burton; Alan R Zinsmeister
Journal:  Dig Dis Sci       Date:  2012-01-21       Impact factor: 3.199

6.  Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.

Authors:  Michael Camilleri; Eric W Klee; Andrea Shin; Paula Carlson; Ying Li; Madhusudan Grover; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-07       Impact factor: 4.052

7.  RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.

Authors:  Michael Camilleri; Paula Carlson; Andres Acosta; Irene Busciglio; Asha A Nair; Simon J Gibbons; Gianrico Farrugia; Eric W Klee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

Review 8.  Pharmacogenetics and the treatment of functional gastrointestinal disorders.

Authors:  Houssam Halawi; Michael Camilleri
Journal:  Pharmacogenomics       Date:  2017-07-07       Impact factor: 2.533

Review 9.  What's in the pipeline for lower functional gastrointestinal disorders in the next 5 years?

Authors:  Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-28       Impact factor: 4.052

Review 10.  Advances in understanding of bile acid diarrhea.

Authors:  Michael Camilleri
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11-25       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.